Where do Royalty Pharma's ratios come from?

Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Royalty Pharma RPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	275.7%-18.9pp	294.6%+8.5pp	286.1%-2.9pp	289%+36.9pp	252.1%+42.0pp
Net margin	143.3%-14.4pp	157.7%-5.5pp	163.2%-17.9pp	181.1%+14.2pp	166.9%+12.6pp
Returns
Return on equity	34.4%-2.7pp	37.2%-0.7pp	37.9%-3.8pp	41.7%+3.7pp	38%+3.0pp
Return on assets	18.3%-2.1pp	20.3%-0.9pp	21.2%-2.7pp	23.9%+1.8pp	22.1%+1.7pp
Return on invested capital	38.3%-2.9pp	41.2%+1.0pp	40.2%-0.9pp	41%+5.0pp	36%+5.8pp
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Liquidity
Current ratio	9.8×+1.1×	8.7×+1.0×	7.7×+1.9×	5.8×-8.1×	13.9×-11.0×
Quick ratio	9.8×+1.1×	8.7×+1.0×	7.7×+1.9×	5.8×-8.1×	13.9×-11.0×
Cash ratio	4.4×+0.2×	4.2×+0.2×	4×+1.0×	3×-5.9×	8.9×-5.8×
Leverage
Debt-to-equity	3.6×+0.1×	3.5×+0.2×	3.3×+0.2×	3.1×+0.1×	3×+0.2×
Debt-to-assets	1.8×0.0×	1.8×0.0×	1.8×0.0×	1.7×0.0×	1.7×+0.1×
Interest coverage	22.2×-3.0×	25.2×-0.7×	25.8×-2.0×	27.8×+1.8×	26×+2.6×
Per Share
Book value per share	$69.15+1.4%	$68.22-0.3%	$68.41-0.2%	$68.53+0.8%	$67.97+0.6%
Valuation
Market capitalization	$67.54B+11.7%	$60.48B+9.4%	$55.3B+4.9%	$52.73B+6.7%	$49.42B-0.2%
Enterprise value	$99.7B+9.8%	$90.78B+8.2%	$83.93B+4.9%	$79.99B+6.5%	$75.13B+1.6%
Price / earnings	81×+12.5×	68.5×+8.2×	60.3×+8.8×	51.5×-2.8×	54.3×-4.6×
Price / sales	28.5×+2.5×	26×+1.9×	24.1×+0.9×	23.2×+1.3×	21.9×-0.1×
Price / book	7×+0.7×	6.3×+0.6×	5.7×+0.3×	5.3×+0.4×	4.9×0.0×
EV / sales	42×+3.0×	39×+2.5×	36.5×+1.4×	35.1×+1.9×	33.3×+0.4×
Earnings yield	20.4%-4.1pp	24.5%-2.9pp	27.4%-4.0pp	31.4%+1.1pp	30.4%+2.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Royalty Pharma's ratios come from?: Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.